- Country: UAE
- Summary: Ipr12254566/rfq22202943/dh/should
- AET Ref No: 74226121
- Deadline: 14 Nov 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: tender_171998
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Ipr12254566 /Rfq22202943/Dh/Ska
Opportunity Description : DescriptionImportant Note : Kindly enter the unit price or the item value WITHOUT the VAT, also ensure to select the VAT category for each item quoted. -
Important Note : If the VAT is applied, will be added at PO stage.
For any questions or clarifications in regards to the VAT, kindly contact Federal Tax Authority.
-
1: INJ. HUMAN NORMAL IMMUNOGLOBULIN 30GM/300ML ( HYQVIA ) FOR S/C USE - 6 EA
2: INJ. HUMAN NORMAL IMMUNOGLOBULIN 10GM/100ML ( HYQVIA ) FOR S/C USE - 8 EA
Response Currency : AED
Closing date : 14/11/2022 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINIpr12254566/rfq22202943/dh/should - UAE Tender
The DUBAI HEALTH AUTHORITY, a Government sector organization in UAE, has announced a new tender for Ipr12254566/rfq22202943/dh/should. This tender is published on UAETenders under AET Ref No: 74226121 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-11-14.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
